Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Genet Test Mol Biomarkers ; 14(2): 157-62, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20059379

ABSTRACT

Autosomal recessive hereditary inclusion body myopathy (HIBM or IBM2) is a progressive adult onset muscle wasting disorder characterized by sparing of the quadriceps. IBM2 is also known as distal myopathy with rimmed vacuoles or nonaka myopathy. IBM2 is associated with mutations in the UDP-GlcNAc 2-Epimerase/ManNAc Kinase gene (GNE). GNE is the rate-limiting enzyme of N-Acetylneuraminate (Neu5Ac, Sialic acid) biosynthesis. The GNE coding region of 64 symptomatic patients were sequenced. Twenty-eight patients were found to bear GNE mutations. Ten novel mutations were identified among nine patients, including four nonsense (p.R8X, p.W204X, p.Q436X, and p.S615X) and five missense (p.R71W, p.I142T, p.I298T, p.L556S, and p.E2G) variations spanning both the epimerase and kinase domains of GNE. Additionally, a synonymous variation (p.Y591Y, codon tac > tat) was seen in a patient bearing compound heterozygous nonsynonymous mutations (p.S615X and p.Y675H). Six of the nine are Caucasian, one patient is Taiwanese, one patient is Asian Indian, and one patient is of European descent. These findings further expand the clinical and genetic spectrum of IBM2.


Subject(s)
Distal Myopathies/enzymology , Distal Myopathies/genetics , Multienzyme Complexes/genetics , Mutation , Adult , Alleles , Amino Acid Substitution , Codon, Nonsense , DNA Mutational Analysis , Distal Myopathies/pathology , Distal Myopathies/physiopathology , Ethnicity/genetics , Female , Gene Frequency , Humans , Inclusion Bodies/pathology , Male , Middle Aged , Multienzyme Complexes/chemistry , Mutation, Missense , Penetrance , Protein Structure, Tertiary
2.
Ann Neurol ; 66(3): 290-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19798725

ABSTRACT

OBJECTIVE: alpha-Sarcoglycan deficiency results in a severe form of muscular dystrophy (limb-girdle muscular dystrophy type 2D [LGMD2D]) without treatment. Gene replacement represents a strategy for correcting the underlying defect. Questions related to this approach were addressed in this clinical trial, particularly the need for immunotherapy and persistence of gene expression. METHODS: A double-blind, randomized controlled trial using rAAV1.tMCK.hSGCA injected into the extensor digitorum brevis muscle was conducted. Control sides received saline. A 3-day course of methylprednisolone accompanied gene transfer without further immune suppression. RESULTS: No adverse events were encountered. SGCA gene expression increased 4-5-fold over control sides when examined at 6 weeks (2 subjects) and 3 months (1 subject). The full sarcoglycan complex was restored in all subjects, and muscle fiber size was increased in the 3-month subject. Adeno-associated virus serotype 1 (AAV1)-neutralizing antibodies were seen as early as 2 weeks. Neither CD4+ nor CD8+ cells were increased over contralateral sides. Scattered foci of inflammation could be found, but showed features of programmed cell death. Enzyme-linked immunospot (ELISpot) showed no interferon-gamma response to alpha-SG or AAV1 capsid peptide pools, with the exception of a minimal capsid response in 1 subject. Restimulation to detect low-frequency capsid-specific T cells by ELISpot assays was negative. Results of the first 3 subjects successfully achieved study aims, precluding the need for additional enrollment. INTERPRETATION: The finding of this gene replacement study in LGMD2D has important implications for muscular dystrophy. Sustained gene expression was seen, but studies over longer time periods without immunotherapy will be required for design of vascular delivery gene therapy trials.


Subject(s)
Genetic Therapy/methods , Muscular Dystrophies, Limb-Girdle/therapy , Sarcoglycans/deficiency , Sarcoglycans/genetics , Adolescent , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes/immunology , Child , Dependovirus/immunology , Female , Gene Expression/genetics , Gene Transfer Techniques , Humans , Immunotherapy/methods , Male , Membrane Proteins , Muscle Fibers, Skeletal , Muscle, Skeletal/metabolism , Muscular Dystrophies, Limb-Girdle/genetics , Muscular Dystrophies, Limb-Girdle/metabolism , Neutralization Tests , Sarcoglycans/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...